6(R)-(4-Carboxyphenylthio)-5(S)-hydroxy-7(E),9(E),11(Z),14(Z)-eicosatetraenoic acid, commonly referred to by its CAS number 154978-38-8, is a complex fatty acid derivative characterized by its unique structural features, including multiple double bonds and a carboxylic acid functional group. This compound is part of the eicosanoid family, which plays significant roles in various biological processes, including inflammation and cell signaling. The presence of the hydroxyl and carboxylic acid groups contributes to its polar nature, enhancing its solubility in polar solvents. The specific stereochemistry indicated by the (R) and (S) designations suggests that this compound exhibits chiral properties, which can influence its biological activity and interactions with enzymes or receptors. Additionally, the multiple unsaturated bonds in its structure suggest that it may participate in various biochemical pathways, potentially affecting lipid metabolism and inflammatory responses. Overall, this compound is of interest in biochemical research, particularly in the context of its potential therapeutic applications.

6(R)-(4-CARBOXYPHENYLTHIO)-5(S)-HYDROXY-7(E),9(E),11(Z),14(Z)-EICOSATETRAENOIC ACID

154978-38-8: 6(R)-(4-Carboxyphenylthio)-5(S)-hydroxy-7(E),9(E),11(Z),14(Z)-eicosatetraenoic acid, commonly referred to by its CAS number 154978-38-8, is a complex fatty acid derivative characterized by its unique structural features, including multiple double bonds and a carboxylic acid functional group. This compound is part of the eicosanoid family, which plays significant roles in various biological processes, including inflammation and cell signaling. The presence of the hydroxyl and carboxylic acid groups contributes to its polar nature, enhancing its solubility in polar solvents. The specific stereochemistry indicated by the (R) and (S) designations suggests that this compound exhibits chiral properties, which can influence its biological activity and interactions with enzymes or receptors. Additionally, the multiple unsaturated bonds in its structure suggest that it may participate in various biochemical pathways, potentially affecting lipid metabolism and inflammatory responses. Overall, this compound is of interest in biochemical research, particularly in the context of its potential therapeutic applications.

BAY u9773

<p>BAY-u9773 is a non-selective CysLT receptor antagonist with similar IC50 for CysLT1 and CysLT2, inhibiting LT responses.</p>

CAS 154978-38-8

6(R)-(4-CARBOXYPHENYLTHIO)-5(S)-HYDROXY-7(E),9(E),11(Z),14(Z)-EICOSATETRAENOIC ACID

BAY u9773

Ref: IN-DA001NIU

BAY-u 9773

Ref: TM-T21864